Navigation Links
Life Sciences Company Sword Diagnostics Moves Operations to Chicago
Date:4/26/2010

University Technology Park at IIT Continues 2010 Growth

Chicago, IL (Vocus) April 26, 2010 -- Sword Diagnostics, Inc., committed to improving healthcare through the use of innovative detection technology, today announced the relocation of its corporate headquarters and research facilities to accommodate planned growth. Double the size of its current space in the suburbs, Sword’s new location at University Technology Park at IIT (UTP) in Chicago marks its shift from start-up venture to growth-stage commercial entity.

Sword launched its proprietary biological detection system in January 2010, closely following the issuance of the company’s core patent. Developed for ultra-sensitive immunoassays, the technology allows greater sensitivity and improved accuracy in disease marker testing, without increasing cost or complexity. Such performance enhancements accelerate gains in basic and clinical research, drug discovery, and clinical diagnostics development, leading to advancements in disease detection.

"This is an important milestone for our company,” said Sword Diagnostics President Dave Dingott. "Our new facility at UTP not only offers more space, better working conditions for the team and access to university resources, but moving from suburban Chicago into the city also improves Sword’s ability to attract top talent with its metropolitan location – all key factors in our continued growth.

"The UTP lease allows us to expand into adjacent suites as the need arises without prematurely incurring costs. Wexford’s flexibility and willingness to partner with its tenants is critically important to high growth-stage companies like Sword Diagnostics.”

"Sword is a great example of the type of life science company that the Technology Business Center within UTP is designed for and dedicated to supporting,” said Catherine E. Vorwald, director of business development for Wexford Science + Technology, LLC. "UTP and IIT are able to offer Sword the resources, expertise, and environment it will need to grow and expand for many years to come. We are proud to add Sword to our growing roster of UTP tenants.”

Sword Diagnostics, Therapeutic Proteins, Chromatin, and Wrightwood Technologies will be among the UTP tenants who will participate in the Association of University Park’s (AURP) BioParks 2010 tour and reception at IIT on May 1. For more information on the two-day program, visit www.aurp.net/bioparks2010.

About Sword Diagnostics

Sword Diagnostics is a life sciences company committed to improving healthcare through the use of innovative detection technology. Selling to research facilities in pharmaceutical companies, academia and government, Sword helps its customers develop more sensitive biomarker tests without increasing cost or complexity. Sword’s patented biological detection technology accelerates the identification of existing and emerging disease markers, making researchers’ dream of early disease detection a reality. For more information, visit http://www.sworddiagnostics.com.

About University Technology Park at IIT (UTP)
The University Technology Park at IIT (UTP) is home to more than 20 emerging
technology-based companies and the Illinois Institute of Technology’s Pritzker Institute for Biomedical Science + Engineering. Launched in 2006, UTP's mission is to move innovation forward by providing quality flexible lab and office space for technology companies at every stage of their growth, and by offering tenants the resources of IIT and the community. The park's four-building complex includes the Technology Business Center (TBC), a technology incubator, a 19-story office tower, and the IIT Research Institute. For more information, visit http://www.universitytechnologypark.com.

About Wexford Science & Technology, LLC
Wexford Science & Technology, LLC (www.wexfordequities.com) is a privately held real estate investment and development company that delivers the real estate solution for science, technology, and healthcare based organizations. Headquartered in Baltimore, Wexford Science & Technology has projects in the contiguous United States with the University of Maryland, Baltimore, The Science Center (Philadelphia), Illinois Institute of Technology, Old Dominion University, the Hershey Center for Applied Research (Hershey Trust) , the University of Miami, and Wake Forest University.

For more information, contact:
Catherine E. Vorwald
Director, Business Development
Wexford Science + Technology, LLC
(443) 844-4172

Dave Dingott
President
Sword Diagnostics, Inc.
312-235-3661

# # #

Read the full story at http://www.prweb.com/releases/Sword/Diagnostics/prweb3927284.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related biology technology :

1. Kinovate Life Sciences, Inc. and Nitto Denko Corporation Announce Launch of NittoPhaseHL – High Loaded Solid Support for Oligonucleotide Synthesis
2. Caliper Life Sciences to Present at Deutsche Banks 35th Annual Health Care Conference
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2010 Financial Results
4. NeoStem, Inc. and ImmuneRegen BioSciences(R) Announce a Collaborative Agreement to Advance Stem Cell Technology
5. Association for Environmental Health & Sciences Foundation and Adventus Group Recognize Future Environmental Science Leaders
6. Neurocrine Biosciences, Inc. Announces Exercise of Over-Allotment Option for Common Stock Offering
7. YM BioSciences announces AACR acceptance of two nimotuzumab poster presentations
8. Advanced Life Sciences Receives FDA Guidance on Approval Pathway for Restanza in Community Acquired Bacterial Pneumonia and Biodefense Indications
9. Neurocrine Biosciences to Present at the Roth 22nd Annual OC Growth Conference
10. YM BioSciences closes US$17.5 million financing
11. YM BioSciences to raise approximately US$15 million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/11/2017)... Bay, Florida (PRWEB) , ... October 11, 2017 ... ... and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel ... (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the cell ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives of the ... for Excellence in Volunteer Experience from US2020. , US2020’s mission is to change ...
(Date:10/10/2017)... Oct. 10, 2017 SomaGenics announced the receipt ... to develop RealSeq®-SC (Single Cell), expected to be the ... RNAs (including microRNAs) from single cells using NGS methods. ... need to accelerate development of approaches to analyze the ... "New techniques for measuring levels of mRNAs in ...
Breaking Biology Technology:
(Date:8/23/2017)... , Aug. 23, 2017  The general public,s help is being enlisted ... bacteria that live in and on the human body –and are believed ... The Microbiome Immunity ... human microbiome, starting with the gut. The project's goal is to help ... credit: IBM ...
(Date:6/14/2017)...  IBM (NYSE: IBM ) is introducing several innovative ... to developing collaboration between startups and global businesses, taking place ... the event, nine startups will showcase the solutions they have ... France is one ... a 30 percent increase in the number of startups created ...
(Date:4/24/2017)... , April 24, 2017 ... and partner with  Identity Strategy Partners, LLP (IdSP) ... "With or without President Trump,s March 6, 2017 ... Terrorist Entry , refugee vetting can be instilled with ... resettlement. (Right now, all refugee applications are suspended ...
Breaking Biology News(10 mins):